Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, novembre 17
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Anavex Life Sciences Corp
AVXL
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.8300
0.0124
1.52%
À la clôture: Nov 17, 4:00 PM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Anavex Life Sciences Financials
Anavex Life Sciences (AVXL) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Anavex Life Sciences Q3 EPS $0.08 Beats $(0.08) Estimate
Anavex Life Sciences (NASDAQ:AVXL) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.08) by 200 percent. This is a 150 percent increase over losses of $(0.16) per share from
Benzinga Newsdesk
PRO
Anavex Life Sciences Q2 EPS $(0.06) Beats $(0.08) Estimate
Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 53.85 percent increase over losses of $(0.13) per share
Benzinga Newsdesk
PRO
Anavex Life Sciences Reports Preliminary Q2 Net Loss Of $0.06 Per Share vs. $0.13 A Year Ago; $127.4M Cash Funds Operations Into Mid-To-Late Fiscal 2028
Benzinga Newsdesk
PRO
Anavex Life Sciences Q1 EPS $(0.06) Beats $(0.11) Estimate
Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 57.14 percent increase over losses of $(0.14) per share
Benzinga Newsdesk
Earnings Scheduled For February 9, 2026
Benzinga Insights
Anavex Life Sciences's Earnings Outlook
Benzinga Insights